Plunkett Research Online: Lixte Biotechnology Holdings Inc

LIXTE BIOTECHNOLOGY HOLDINGS INC (LIXT:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Lixte Biotech Holding, Inc. is currently developing new treatments for several human cancers. The main focus is on the most common and most aggressive type of brain cancer of adults, glioblastoma multiforme. Additionally, the company, however, has expanded the scope of its drug development program t.....



Lixte Biotechnology Holdings Inc
Ticker: LIXT
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 631 942 7959
Fax: 928 982 5050
Address: 248 Route 25A, No. 2
East Setauket, NY 11733 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
John KovachCEO/Director/Founder/CFO
Philip PalmedoDirector
See More
Lixte Biotech Holding, Inc. is currently developing new treatments for several human cancers. The main focus is on the most common and most aggressive type of brain cancer of adults, glioblastoma multiforme. Additionally, the company, however, has expanded the scope of its drug development program t.....See More See More

Auditor: WEINBERG & COMPANY, P.A.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: